CERE NASDAQ
Cerevel Therapeutics Holdings, Inc.
1W: +1.3%
1M: +9.1%
3M: +5.5%
1Y: +46.7%
3Y: +79.5%
$44.96
Last traded 2024-08-01 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$1.2B
+22.2% ▲
5Y CAGR: +291.3%
Total Liabilities
$570M
+14.7% ▲
5Y CAGR: +141.7%
Shareholders Equity
$674M
+29.3% ▲
5Y CAGR: +175.9%
Cash & Investments
$991M
+11.1% ▲
5Y CAGR: +161.6%
Total Debt
$481M
+31.1% ▲
5Y CAGR: +155.7%
Net Debt
-$510M
-321.7% ▼
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $80M | $384M | $193M | $137M | $991M |
| Short-Term Investments | $0 | $0 | $373M | $756M | $0 |
| Cash & ST Investments | $80M | $384M | $566M | $892M | $991M |
| Net Receivables | $0 | $0 | $729K | $0 | $5M |
| Inventory | $0 | $0 | -$729K | -$2M | $0 |
| Other Current Assets | $8M | $7M | $12M | $14M | $11M |
| Total Current Assets | $87M | $391M | $578M | $906M | $1.0B |
| Property, Plant & Equip. | $27M | $49M | $52M | $49M | $46M |
| Goodwill & Intangibles | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $4M | $52M | $58M | $187M |
| Other Non-Current Assets | $6M | $2M | $7M | $5M | $3M |
| Total Non-Current Assets | $34M | $55M | $111M | $112M | $236M |
| Total Assets | $121M | $445M | $689M | $1.0B | $1.2B |
| — Liabilities — | |||||
| Accounts Payable | $2M | $5M | $11M | $10M | $12M |
| Short-Term Debt | $3M | $2M | $2M | $3M | $3M |
| Deferred Revenue | $10M | $22M | $28M | $0 | $0 |
| Other Current Liabilities | $10M | $23M | $29M | $60M | $77M |
| Total Current Liabilities | $15M | $30M | $43M | $73M | $92M |
| Long-Term Debt | $26M | $31M | $34M | $367M | $365M |
| Other Non-Current Liab. | $2M | $236K | $34M | $57M | $112M |
| Total Non-Current Liabilities | $28M | $31M | $68M | $424M | $477M |
| Total Liabilities | $43M | $61M | $110M | $497M | $570M |
| — Equity — | |||||
| Common Stock | $6K | $13K | $15K | $16K | $18K |
| Retained Earnings | -$244M | -$391M | -$616M | -$968M | -$1.4B |
| Accumulated OCI | $0 | $0 | -$986K | $3M | $2M |
| Total Stockholders Equity | $78M | $385M | $579M | $521M | $674M |
| Total Liabilities & Equity | $121M | $445M | $689M | $1.0B | $1.2B |
| — Key Metrics — | |||||
| Total Debt | $28M | $33M | $37M | $367M | $481M |
| Net Debt | -$51M | -$351M | -$156M | $230M | -$510M |
| Total Investments | $0 | $4M | $425M | $814M | $187M |